RESUMO
Para rubber seed was macerated in petroleum ether and n-hexane, individually, for 30 min. The extraction was additionally performed by reflux and soxhlet for 6 h with the same solvent and proportion. Soxhlet extraction by petroleum ether afforded the greatest extractive yield (22.90 ± 0.92%). Although antioxidant activity by means of 1, 1-diphenyl-2-picrylhydrazyl (DPPH) assay was insignificantly differed in soxhleted (8.90 ± 1.15%) and refluxed (9.02 ± 0.71%) by n-hexane, soxhlet extraction by n-hexane was significantly (p < 0.05) potent scavenged 2,2'-azino-bis(3-ethylbenzothaiazoline)-6-sulfonic acid) or ABTS radical with trolox equivalent antioxidant capacity (TEAC) of 66.54 ± 6.88 mg/100 g oil. This extract was non cytotoxic towards normal human fibroblast cells. In addition, oleic acid and palmitic acid were determined at a greater content than in the seed of para rubber cultivated in Malaysia, although linoleic and stearic acid contents were not differed. This bright yellow extract was further evaluated on other physicochemical characters. The determined specific gravity, refractive index, iodine value, peroxide value and saponification value were in the range of commercialized vegetable oils used as cosmetic raw material. Therefore, Para rubber seed oil is highlighted as the promising ecological ingredient appraisal for cosmetics. Transforming of the seed that is by-product of the important industrial crop of Thailand into cosmetics is encouraged accordingly.
Assuntos
Cosméticos , Gorduras Insaturadas , Células Cultivadas , Fenômenos Químicos , Gorduras Insaturadas/química , Gorduras Insaturadas/isolamento & purificação , Gorduras Insaturadas/farmacocinética , Fibroblastos/efeitos dos fármacos , Sequestradores de Radicais Livres , Humanos , Ácido Oleico/análise , Ácido Palmítico/análise , Pele/citologia , TailândiaRESUMO
Changes in the diet pattern have been considered a major cause of overweight rate increase and Metabolic Syndrome (MS) in the world. A diet with high energy density can contribute to fat accumulation in metabolic active tissues and increase of proinflammatory adipokines, favoring the inflammatory condition of this syndrome. However, not all types of high fat diet are malefic to the body. The objective of this study was to conduct a literature review on the effect of fatty acids on the Metabolic Syndrome and on the important relationship between diet, obesity, MS and cardiovascular disease. It was possible to observe that a diet rich in saturated fat is associated with overweight, non-alcoholic fatty liver disease, and increased levels of cholesterol, leptin, insulin and glucose. It was also possible to observe that increased levels of saturated fatty acids and decreased levels of polyunsaturated fatty acids are associated with metabolic syndrome. Supplementation with ?-3 was effective in reducing the effects of saturated fatty acids, such as the serum levels of triglycerides, total cholesterol, LDL-c, decreasing blood pressure, and increasing the serum levels of HDL-c. After further studies confirm the safety of use and the ideal dose of ?-3 to prevent and treat MS, the supplementation should be associated with a diet that is balanced, low in saturated fat and rich in vitamins, as well as with a change in lifestyle.
Los cambios en los hábitos alimentícios han sido considerados como una de las causas más importantes del aumento mundial del sobrepeso y, por lo tanto, del Síndrome Metabólico (SM). Una dieta con alta densidad energética puede contribuir a la acumulación de grasa en los tejidos metabólicamente activos y al aumento de adipoquinas proinflamatorias, favoreciendo, así, el cuadro inflamatorio de este síndrome. Sin embargo, no todos los tipos de dietas hiperlipídicas son perjudiciales para el organismo. Por lo tanto, el objetivo de este estudio fue revisar en la literatura los efectos de los ácidos grasos en el SM y la importante relación entre dieta, obesidad, síndrome metabólico y enfermedad cardiovascular. Se observó que una dieta rica en grasas saturadas se asocia con el exceso de peso, hígado graso, elevación de los niveles séricos de colesterol, leptina, insulina y glucosa, puesto que el alto consumo de grasas saturadas y la disminución de los niveles de ácidos grasos poliinsaturados se correlacionan con el Síndrome Metabólico. La ingesta de suplementos de ácidos grasos poliinsaturados ha demostrado su eficacia a la hora de mitigar los efectos de la dieta alta en grasas, además de reducir los triglicéridos, el colesterol total, LDL-c, la presión arterial y mejorar los niveles de HLD-c. Después de que estudios posteriores confirmen la seguridad del uso y la dosis ideal del Omega 3 para la prevención y el tratamiento del Síndrome Metabólico, se hace necesario que su uso sea associado con una dieta balanceada, baja en grasas saturadas, rica en vitaminas, e incentivar al cambio en el estilo de vida.
As mudanças nos padrões alimentares têm sido consideradas como uma das principais causas do aumento mundial do excesso de peso e, consequentemente, da Síndrome Metabólica (SM). Uma dieta com alta densidade energética pode contribuir para acúmulo de gordura em tecidosmetabolicamente ativos e aumento de adipocinas pró-inflamatórias, favorecendo o quadro inflamatório desta Síndrome. Porém, nem todos ostipos de dietas hiperlipídicas são maléficos para o organismo. Assim, o presente estudo teve como objetivo revisar na literatura os efeitos dos ácidos graxos na SM e a importante relação entre dieta, obesidade, SM e doenças cardiovasculares. Observou-se que a alimentação rica em gordura saturada está relacionada com excesso de peso, esteatose hepática, elevação dos níveis séricos de colesterol, leptina, insulina e glicose, sendo que a elevação do consumo de gordura saturada ea diminuição de ácidos graxos poli-insaturados estão correlacionadas com a presença da Síndrome Metabólica. A suplementação de ácidograxo poli-insaturado mostrou-se eficaz para amenizar os efeitos da dieta hiperlipídica, além de diminuir triglicérides, colesterol total, LDL-c e pressão arterial, e melhorar os níveis de HLD-c. Após estudos posteriores confirmarem a segurança e a dose da utilização do ômega 3 para prevenção e tratamento da Síndrome Metabólica, é necessário que esta utilização seja associada a uma dieta equilibrada, pobre em gordura saturada, rica em vitaminas e com um incentivo à mudança no estilo de vida.
Assuntos
Ácidos Graxos/classificação , Síndrome Metabólica/classificação , Gorduras Insaturadas/farmacocinética , Ácidos Graxos Ômega-3/farmacocinética , ObesidadeRESUMO
The lymphatic transport and the portal absorption of the lipophilic drug halofantrine were investigated in a conscious rat model. The rats were dosed with 0.1 g with triolein, trilinolein or trilinolenin containing 2 mg halofantrine. Following oral administration of the triglycerides, the mesenteric lymph and plasma samples were collected. The lymphatic transport for halofantrine was 11.1+/-1.2 after administration of trilinolein, 9.0+/-3.5 for trilinolenin and 8.6+/-2.2 for triolein and the total amount of halofantrine transported in the lymph was linear proportional with the amount of triglyceride in the lymph. The absorption of halofantrine directly into the blood showed a trend towards a higher AUC for trilinolien and trilinolenin compared to triolein, but no statistical difference could be found. The statistically analysis of the mean total bioavailability therefore shows that the absorption of halofantrine was largely independent on triglyceride unsaturation.
Assuntos
Antimaláricos/farmacocinética , Gorduras Insaturadas/farmacocinética , Sistema Linfático/metabolismo , Fenantrenos/farmacocinética , Triglicerídeos/farmacocinética , Administração Oral , Animais , Antimaláricos/administração & dosagem , Antimaláricos/sangue , Disponibilidade Biológica , Transporte Biológico Ativo , Cateterismo/métodos , Estado de Consciência/fisiologia , Gorduras Insaturadas/administração & dosagem , Masculino , Fenantrenos/administração & dosagem , Fenantrenos/sangue , Ratos , Ratos Sprague-Dawley , Triglicerídeos/administração & dosagem , Triglicerídeos/sangueRESUMO
The aim of this study was to evaluate the potential of an emulsion incorporating unsaturated fatty acids to improve the mucosal absorption of poorly absorbed drugs from rat intestinal loops in situ, using a water-in-oil-in-water (W/O/W) multiple emulsion. Vancomycin hydrochloride (VCM) was used as a model drug with low oral bioavailability. The entrapment efficiency of VCM in the emulsion was approximately 60% and remained constant over storage for 1 month at 4 degrees C. The emulsion incorporating C18 unsaturated fatty acids or docosahexaenoic acid (DHA) markedly enhanced VCM absorption after colonic and rectal dosing. The effectiveness of DHA on VCM colonic absorption improvement was the same as that of oleic acid, and less than that of linoleic and linolenic acids. For rectal dosing, bioavailability was similar among various emulsions, in the range 40-50%. The effect of the emulsion incorporating oleic acid or DHA on improving VCM enteral bioavailability was not increased proportional to the incorporated amount. The electrical resistance of membranes was not changed by the incorporation of various fatty acids in emulsions. Our results indicated that W/O/W emulsions incorporating C18 unsaturated fatty acid or DHA were useful carriers for improving the absorption of poorly absorbable drugs via the intestinal tract without gross changes to tight junction function.